| Shannon Hulliberger, | |
|
1380 E Sherman Blvd, Muskegon, MI 49444-1814 | |
| (262) 309-8991 | |
| Not Available |
| Full Name | Shannon Hulliberger |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1380 E Sherman Blvd, Muskegon, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780359539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 7152000135 (Michigan) | Primary |
| Provider Name | The Shoreline Center Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1942689708 PECOS PAC ID: 5294030938 Enrollment ID: O20160218000349 |
News Archive
Now on Kaiser Health News blog, KUHF's Carrie Feibel, working in partnership with KHN and NPR, reports: "When Ashley Beecher had her first daughter, nursing was a struggle, and she sometimes had to supplement her baby's diet with formula. But when she had her second daughter in January, it was a very different story. … Beecher was reluctant to throw away the milk – mothers and doctors call it 'liquid gold' because of its health benefits -; so she was excited to find out about the donor milk bank at Texas Children's Hospital in Houston."
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
"New models of financing and delivering development programmes are bringing far-reaching changes to the international public sector," with " traditional government-to-government transactions … giving way to complex networks of partners - some of them from the private sector - to provide everything from antiretroviral drugs and girls' education to emergency food supplies," the Financial Times reports in a piece that explores why such changes are taking place and their implications for future funding.
Epizyme, Inc., a biopharmaceutical company translating key discoveries in the field of epigenetics into novel pharmaceutical agents, announced today the participation of New Enterprise Associates (NEA) in its Series B, bringing the total financing to $40M.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Hulliberger, 1848 Preston Ct Nw Apt B95, Grand Rapids, MI 49504-2774 Ph: (262) 309-8991 | Shannon Hulliberger, 1380 E Sherman Blvd, Muskegon, MI 49444-1814 Ph: (262) 309-8991 |
News Archive
Now on Kaiser Health News blog, KUHF's Carrie Feibel, working in partnership with KHN and NPR, reports: "When Ashley Beecher had her first daughter, nursing was a struggle, and she sometimes had to supplement her baby's diet with formula. But when she had her second daughter in January, it was a very different story. … Beecher was reluctant to throw away the milk – mothers and doctors call it 'liquid gold' because of its health benefits -; so she was excited to find out about the donor milk bank at Texas Children's Hospital in Houston."
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
"New models of financing and delivering development programmes are bringing far-reaching changes to the international public sector," with " traditional government-to-government transactions … giving way to complex networks of partners - some of them from the private sector - to provide everything from antiretroviral drugs and girls' education to emergency food supplies," the Financial Times reports in a piece that explores why such changes are taking place and their implications for future funding.
Epizyme, Inc., a biopharmaceutical company translating key discoveries in the field of epigenetics into novel pharmaceutical agents, announced today the participation of New Enterprise Associates (NEA) in its Series B, bringing the total financing to $40M.
› Verified 3 days ago
Julia Tans, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1910 E Apple Ave Ste H, Muskegon, MI 49442 Phone: 231-333-9148 | |
Mrs. Lea Dawn Norbotten, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1080 E Sternberg Rd, Muskegon, MI 49444 Phone: 231-799-2200 Fax: 231-799-2201 | |
Swan Marie Reddy, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 376 E Apple Ave, Muskegon, MI 49442 Phone: 231-724-1111 Fax: 231-724-4188 | |
Michelle Clockman, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 695 Mitzi St, Muskegon, MI 49445 Phone: 231-744-1641 | |
Amy D Ballot, MA,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 635 W Summit Ave, Muskegon, MI 49441 Phone: 888-488-9030 | |
Ms. Kelly Rimbey, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 376 E Apple Ave, Muskegon, MI 49442 Phone: 231-724-1111 Fax: 231-724-1300 | |
Sara Nekic, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 695 Mitzi St, Muskegon, MI 49445 Phone: 231-744-0520 |